Fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae from Asian countries: ANSORP study
Seventeen clinical isolates of Streptococcus pneumoniae showing reduced susceptibility to ciprofloxacin (MIC : 4 mug/ml) collected from eight different Asian countries were analyzed by antimicrobial susceptibility, serotyping, pulsed-field gel electrophoresis (PFGE), and DNA sequencing of the quinol...
| Main Authors: | , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Published: |
Mary Ann Liebert
2004
|
| Subjects: |
| _version_ | 1825718963511754752 |
|---|---|
| author | Oh, W.S. Suh, J.Y. Song, J.H. Ko, K.S. Jung, S.I. Peck, K.R. Lee, N.Y. Yang, Y.H. Chongthaleong, A. Chiu, C.H. Kamarulzaman, Adeeba Parasakthi, N. Lalitha, M.K. Perera, J. Yee, T.T. Kumarasinghe, G. Carlos, C.C. |
| author_facet | Oh, W.S. Suh, J.Y. Song, J.H. Ko, K.S. Jung, S.I. Peck, K.R. Lee, N.Y. Yang, Y.H. Chongthaleong, A. Chiu, C.H. Kamarulzaman, Adeeba Parasakthi, N. Lalitha, M.K. Perera, J. Yee, T.T. Kumarasinghe, G. Carlos, C.C. |
| author_sort | Oh, W.S. |
| collection | UM |
| description | Seventeen clinical isolates of Streptococcus pneumoniae showing reduced susceptibility to ciprofloxacin (MIC : 4 mug/ml) collected from eight different Asian countries were analyzed by antimicrobial susceptibility, serotyping, pulsed-field gel electrophoresis (PFGE), and DNA sequencing of the quinolone resistance-determining regions (QRDRs) in gyrA, gyrB, parC, and parE. All isolates but one showed more than one amino acid alteration in QRDRs of four responsible genes. Ile460 —> Val in parE was the most common mutation. Data suggest that Lys137 —> Asn in parC may be a primary step in the development of high-level and multiple FQ resistance. An additional mutation of Ser81 —> Phe in gyrA resulted in high-level resistance to ciprofloxacin, levofloxacin, and gatifloxacin, whereas Ser79 —> Phe in parC may exert an important role in the development of moxifloxacin resistance. Two novel amino acid changes in gyrB, Ala390 —> Val and Asn423 —> Thr, were found. Data from PFGE suggest an introduction and local spread of multiple resistant Spain(23)F-1 clone in Hong Kong, but isolates from other Asian countries were not related to this clone. |
| first_indexed | 2024-03-06T05:12:19Z |
| format | Article |
| id | um.eprints-4582 |
| institution | Universiti Malaya |
| last_indexed | 2024-03-06T05:12:19Z |
| publishDate | 2004 |
| publisher | Mary Ann Liebert |
| record_format | dspace |
| spelling | um.eprints-45822019-12-03T10:52:00Z http://eprints.um.edu.my/4582/ Fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae from Asian countries: ANSORP study Oh, W.S. Suh, J.Y. Song, J.H. Ko, K.S. Jung, S.I. Peck, K.R. Lee, N.Y. Yang, Y.H. Chongthaleong, A. Chiu, C.H. Kamarulzaman, Adeeba Parasakthi, N. Lalitha, M.K. Perera, J. Yee, T.T. Kumarasinghe, G. Carlos, C.C. R Medicine Seventeen clinical isolates of Streptococcus pneumoniae showing reduced susceptibility to ciprofloxacin (MIC : 4 mug/ml) collected from eight different Asian countries were analyzed by antimicrobial susceptibility, serotyping, pulsed-field gel electrophoresis (PFGE), and DNA sequencing of the quinolone resistance-determining regions (QRDRs) in gyrA, gyrB, parC, and parE. All isolates but one showed more than one amino acid alteration in QRDRs of four responsible genes. Ile460 —> Val in parE was the most common mutation. Data suggest that Lys137 —> Asn in parC may be a primary step in the development of high-level and multiple FQ resistance. An additional mutation of Ser81 —> Phe in gyrA resulted in high-level resistance to ciprofloxacin, levofloxacin, and gatifloxacin, whereas Ser79 —> Phe in parC may exert an important role in the development of moxifloxacin resistance. Two novel amino acid changes in gyrB, Ala390 —> Val and Asn423 —> Thr, were found. Data from PFGE suggest an introduction and local spread of multiple resistant Spain(23)F-1 clone in Hong Kong, but isolates from other Asian countries were not related to this clone. Mary Ann Liebert 2004 Article PeerReviewed Oh, W.S. and Suh, J.Y. and Song, J.H. and Ko, K.S. and Jung, S.I. and Peck, K.R. and Lee, N.Y. and Yang, Y.H. and Chongthaleong, A. and Chiu, C.H. and Kamarulzaman, Adeeba and Parasakthi, N. and Lalitha, M.K. and Perera, J. and Yee, T.T. and Kumarasinghe, G. and Carlos, C.C. (2004) Fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae from Asian countries: ANSORP study. Microbial Drug Resistance, 10 (1). pp. 37-42. ISSN 1076-6294, |
| spellingShingle | R Medicine Oh, W.S. Suh, J.Y. Song, J.H. Ko, K.S. Jung, S.I. Peck, K.R. Lee, N.Y. Yang, Y.H. Chongthaleong, A. Chiu, C.H. Kamarulzaman, Adeeba Parasakthi, N. Lalitha, M.K. Perera, J. Yee, T.T. Kumarasinghe, G. Carlos, C.C. Fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae from Asian countries: ANSORP study |
| title | Fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae from Asian countries: ANSORP study |
| title_full | Fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae from Asian countries: ANSORP study |
| title_fullStr | Fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae from Asian countries: ANSORP study |
| title_full_unstemmed | Fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae from Asian countries: ANSORP study |
| title_short | Fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae from Asian countries: ANSORP study |
| title_sort | fluoroquinolone resistance in clinical isolates of streptococcus pneumoniae from asian countries ansorp study |
| topic | R Medicine |
| work_keys_str_mv | AT ohws fluoroquinoloneresistanceinclinicalisolatesofstreptococcuspneumoniaefromasiancountriesansorpstudy AT suhjy fluoroquinoloneresistanceinclinicalisolatesofstreptococcuspneumoniaefromasiancountriesansorpstudy AT songjh fluoroquinoloneresistanceinclinicalisolatesofstreptococcuspneumoniaefromasiancountriesansorpstudy AT koks fluoroquinoloneresistanceinclinicalisolatesofstreptococcuspneumoniaefromasiancountriesansorpstudy AT jungsi fluoroquinoloneresistanceinclinicalisolatesofstreptococcuspneumoniaefromasiancountriesansorpstudy AT peckkr fluoroquinoloneresistanceinclinicalisolatesofstreptococcuspneumoniaefromasiancountriesansorpstudy AT leeny fluoroquinoloneresistanceinclinicalisolatesofstreptococcuspneumoniaefromasiancountriesansorpstudy AT yangyh fluoroquinoloneresistanceinclinicalisolatesofstreptococcuspneumoniaefromasiancountriesansorpstudy AT chongthaleonga fluoroquinoloneresistanceinclinicalisolatesofstreptococcuspneumoniaefromasiancountriesansorpstudy AT chiuch fluoroquinoloneresistanceinclinicalisolatesofstreptococcuspneumoniaefromasiancountriesansorpstudy AT kamarulzamanadeeba fluoroquinoloneresistanceinclinicalisolatesofstreptococcuspneumoniaefromasiancountriesansorpstudy AT parasakthin fluoroquinoloneresistanceinclinicalisolatesofstreptococcuspneumoniaefromasiancountriesansorpstudy AT lalithamk fluoroquinoloneresistanceinclinicalisolatesofstreptococcuspneumoniaefromasiancountriesansorpstudy AT pereraj fluoroquinoloneresistanceinclinicalisolatesofstreptococcuspneumoniaefromasiancountriesansorpstudy AT yeett fluoroquinoloneresistanceinclinicalisolatesofstreptococcuspneumoniaefromasiancountriesansorpstudy AT kumarasingheg fluoroquinoloneresistanceinclinicalisolatesofstreptococcuspneumoniaefromasiancountriesansorpstudy AT carloscc fluoroquinoloneresistanceinclinicalisolatesofstreptococcuspneumoniaefromasiancountriesansorpstudy |